Despite a 6% revenue increase, Hermes' volume growth was flat. Read why this is a golden opportunity for long-term-oriented ...
CEO Jason Kim said, "Firefly opened the year with strong execution and increasing momentum driven by major government programs that align directly with our core capabilities." He added, "We delivered ...
Hello, and welcome to Nuvation Bio's First Quarter 2026 Financial Results and Corporate Update Call. Today's call is being recorded, and a replay will be available on the company's website. [Operator ...
Treasury yields from 2 years to 30 years spiked today – along with crude oil prices and inflation fears – after Iranian ...
April 2026 brought a broad recovery across asset classes, reversing much of March’s losses. U.S. stocks led the month at ...
" (Chairman & CEO Ellison) "Approximately 80% of our engineering organization is using code-assisted technology, which is driving meaningful production gains and really cutting approval times by more ...
Q1 2026 earnings call recap: direct-member pivot, 15% price hike, churn/ARPU targets, cash flow and Q4 breakeven outlook—read now.
Welcome to Gaia's First Quarter 2026 Earnings Conference Call. [Operator Instructions] Joining us today from Gaia are Jirka Rysavy, Chairman; Kiersten Medvedich, CEO and Ned Preston, CFO. [Operator ...
Q1 2026 earnings call recap: revenue miss on reimbursement mix, guidance cut to $475–$490M, 30%+ volume growth.
Q1 2026 earnings call: 42% revenue growth, margin expansion, Nodify Lung adoption and raised 2026 guidance to $108–$114M—read now.
Palantir is heavily reliant on U.S. government contracts, with international military expansion facing significant barriers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results